Decisión del Panel Administrativo nº D2019-0161 of WIPO Arbitration and Mediation Center, March 11, 2019 (case F. Hoffmann-La Roche AG v. Privacy Administrator, Anonymize, Inc. / Jan Janssen, Pelres Investments Ltd.)

• Resolution Date: March 11, 2019
• Issuing Organization: WIPO Arbitration and Mediation Center
• Decision: Transfer
• Dominio: Generic Domains

WIPO Arbitration and Mediation Center

ADMINISTRATIVE PANEL DECISION

F. Hoffmann-La Roche AG v. Privacy Administrator, Anonymize, Inc. / Jan Janssen, Pelres Investments Ltd.

Case No. D2019-0161

1. The Parties

Complainant is F. Hoffmann-La Roche AG of Basel, Switzerland, internally represented.

Respondent is Privacy Administrator, Anonymize, Inc. of Sammamish, Washington, United States of America (“United States”) / Jan Janssen, Pelres Investments Ltd., of Basingstoke, North Hampshire, United Kingdom.

2. The Domain Name and Registrar

The disputed domain name [accutane.org] (“Domain Name”) is registered with Epik, Inc. (the “Registrar”).

3. Procedural History

The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on January 24, 2019. On January 24, 2019, the Center transmitted by email to the Registrar a request for registrar verification in connection with the Domain Name. On January 30, 2019, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the Domain Name which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to Complainant on January 31, 2019, providing the registrant and contact information disclosed by the Registrar, and inviting Complainant to submit an amendment to the Complaint. Complainant filed an amendment to the Complaint on January 31, 2019.

The Center verified that the Complaint, together with the amendment to the Complaint, satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”).

In accordance with the Rules, paragraphs 2 and 4, the Center formally notified Respondent of the Complaint, and the proceedings commenced on January 31, 2019. In accordance with the Rules, paragraph 5, the due date for Response was February 20, 2019. Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on February 21, 2019.

The Center appointed Marina Perraki as the sole panelist in this matter on February 25, 2019. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7.

4. Factual Background

According to the Complaint, Complainant is, together with its affiliated companies, one of the world’s leading healthcare groups in the fields of pharmaceuticals and diagnostics with global operations in more than 100 countries.

Complainant’s group holds numerous trademark registrations for the ACCUTANE mark, and its alternative forms...